950160 · KOSDAQ · Based on DART filings
3 total · 20 per page
· Periodic Report
Kolon TissueGene sold KRW 1.6 billion in Q3 and lost KRW 11.7 billion in its main business, but its net profit turned positive at KRW 120.7 billion.
· LitigationAmended
The claim amount in the damages suit by Lee Eun-suk and 948 others was changed to KRW 28.4 billion.
· LitigationAmended
The claim in the damages suit by Kang Kyung-seok and 283 others was corrected to KRW 8.9 billion.
Get app alerts for new disclosures from Kolon TissueGene, Inc..
